Natera Files Petition for IPR Against Illumina’s Fetal Abnormality Detection Patent

July 2, 2018 – On June 29, 2018, Natera, Inc. filed a petition for inter partes review against Illumina’s fetal abnormality detection patent.

The patent at issue is U.S. Patent No. 9,493,831, entitled “Methods of fetal abnormality detection.” The case is captioned Natera, Inc. v. Illumina, Inc., Case No. IPR2018-01317.

By: Julian G. Pymento